SCHEMBL10169940

SCHEMBL10169940

CCCN1CC(Oc2ccc(-c3c(-c4ccccc4Cl)noc3-c3ccc(O)c(C)c3)cc2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 5/20 0.39
ALOX5 P09917 1/20 0.38
ALOX5AP P20292 1/20 0.38
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
MAPT P10636 2/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSP90AA1 P07900 4/20 0.34
DCTPP1 Q9H773 2/20 0.34
TP53 P04637 1/20 0.34
USP2 O75604 1/20 0.34
USP1 O94782 1/20 0.34
USP8 P40818 1/20 0.34
OTUB1 Q96FW1 1/20 0.34
HSP90AB1 P08238 1/20 0.34
PDK1 Q15118 1/20 0.34
PIM1 P11309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL9957346 0.93 HSP90AA1 (0.36) ESR1ALOX5ALOX5APPTGS1PTGS2
SCHEMBL9956414 0.89 ESR1 (0.46) ESR1ALOX5ALOX5APPTGS1PTGS2
Hydrochloric Acid SCHEMBL9955635 0.88 ESR1 (0.45) ESR1ALOX5ALOX5APPTGS1PTGS2
SCHEMBL10169917 0.88 ESR1 (0.44) ESR1ALOX5ALOX5APPTGS1PTGS2
SCHEMBL9957351 0.85 MAPT (0.36) ESR1ALOX5ALOX5APMAPTS1PR1
SCHEMBL10169926 0.84 ESR1 (0.41) ESR1ALOX5ALOX5APPTGS1PTGS2
Hydrochloric Acid SCHEMBL9955889 0.83 ESR1 (0.40) ESR1ALOX5ALOX5APPTGS1PTGS2
SCHEMBL10169927 0.83 ESR1 (0.47) ESR1ALOX5ALOX5APMAPTS1PR1
Trifluoroacetic Acid SCHEMBL9957056 0.82 ESR1 (0.40) ESR1ALOX5ALOX5APS1PR1S1PR3
SCHEMBL9957059 0.81 MAPT (0.36) ESR1ALOX5ALOX5APMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
WO-2012084711-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MSD OSS B.V. (NL) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES ESR2, ESR1, GPER1 ESR1 2/4885ALOX5 1043/4885ALOX5AP 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.